The DOI matches its Crossref record.
Central sympathomimetic activity of (+)‐5‐methyl‐10,11‐dihydro‐5H‐dibenzo [a, d]cyclohepten‐5,10‐imine (MK‐801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties
Abstract
MK‐801 at doses < 100 μg/kg given orally induced an ipsilaterally directed directed rotational response in rats with a unilateral nigrostriatal lesion produced by 6‐hydroxydopamine. (+)‐Amphetamine, amfonelic acid, and methylphenidate also evoked ipsilateral turning with their dose‐response lines lying considerably to the right of that for MK‐801. Rotations caused by a standard test dose of 50 μg/kg of MK‐801 were reduced by pretreatment with haloperidol (ED 50 = 0.068 mg/kg IP), clozapine (ED 50 = 3.35 mg/kg IP), or prazosin (ED 50 = 0.15 mg/kg SC). MK‐801‐induced turning was also inhibited by pretreatment with α‐methyl‐p‐tyrosine (α‐MPT) and blocked by reserpine. Locomotor activity in mice was increased by MK‐801, amfonelic acid, (+)‐amphetamine, and methylphenidate. Following administration p.o., MK‐801 was the most potent in this regard and methylphenidate the least. Stimulation of locomotor activity by equivalent doses of the four compounds was differentially affected by pretreatment with α‐MPT or reserpine, Reserpinization abolished the increase in activity usually produced by MK‐801, amfonelic acid and methylphenidate, whereas (+)‐amphetamine was only partially (36%) inhibited. Locomotor stimulation by (+)‐amphetamine was, on the other hand, markedly reduced in α‐MPT‐pretreated mice, while the actions of the other three compounds were not singnificantly altered. The ability of all four compounds to increase motor activity was significantly antagonized by haloperidol, but prazosin at the dose (3 mg/kg SC) examined was an effective antagonist of only MK‐801 and (+)‐amphetamine. MK‐801 has effects in rodents resembling indirect‐acting central sympathomimetic substances such as amfonelic acid, (+)‐amphetamine, and methylphenidate. The central sympathomimetic actions of MK‐801 are mediated via catecholamine‐dependent processes. Results from the drug‐interaction studies in mice (locomotor activity) indicate that the precise mechanism of action of MK‐801 differs from that of the other three compounds.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Carlsson, M., & Carlsson, A. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90108-m · Cited by 1,082
Excitatory amino acids in the brain - focus on NMDA receptors
Cotman, C. W., & Iversen, L. L. (1987) · Trends in Neurosciences · doi:10.1016/0166-2236(87)90170-6 · Cited by 637
The glutamate antagonist MK‐801 reduces focal ischemic brain damage in the rat
Park, C. K., Nehls, D. G., Graham, D. I., Teasdale, G. M., & McCulloch, J. (1988) · Annals of Neurology · doi:10.1002/ana.410240411 · Cited by 539
Clineschmidt, B. V., Martin, G. E., & Bunting, P. R. (1982) · Drug Development Research · doi:10.1002/ddr.430020203 · Cited by 498
Self-citationBlockade of “reverse tolerance” to cocaine and amphetamine by MK-801
Karler, R., Calder, L. I., Chaudhry, I. A., & Turkanis, S. A. (1989) · Life Sciences · doi:10.1016/0024-3205(89)90045-3 · Cited by 488
Metadata
- Authors
- Clineschmidt, B. V., Martin, G. E., Bunting, P. R., & Papp, N. L.
- Venue
- Drug Development Research
- Publisher
- Wiley
- Published
- 1982-01
- Volume
- 2
- Issue
- 2
- Pages
- 135-145
- ISSN
- 0272-4391 (ISSN-L)
- 1098-2299
- OpenAlex
- W4237774983
- Cited by
- 230
- References
- 0
- FWCI
- 0.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Central sympathomimetic activity of (+)‐5‐methyl‐10,11‐dihydro‐5H‐dibenzo [a, d]cyclohepten‐5,10‐imine (MK‐801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties. https://app.cochat.ai/papers/10.1002/ddr.430020204
- The paper
- Clineschmidt, B. V., Martin, G. E., Bunting, P. R., & Papp, N. L. (1982). Central sympathomimetic activity of (+)‐5‐methyl‐10,11‐dihydro‐5H‐dibenzo [a, d]cyclohepten‐5,10‐imine (MK‐801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties. Drug Development Research. https://doi.org/10.1002/ddr.430020204
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.